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Abstract
 
            Hepatoprotective effects of Rheum emodi roots and their aqueous and methanolic extracts were studied 
against liver damage induced by paracetamol in albino rats. In addition, the effects of herbal preparation, Akseer-e-
Jigar and a control drug, silymarin were also studied. Pretreatment and post-treatment hepatoprotective effects of all 
these drugs were determined. The prevention of liver damage and curative effects of the drugs were judged by 
changes in serum ALT, AST, ALP, albumin and bilirubin (total and direct) levels. Powdered Rheum emodi roots (1 
and 1.5 g/kg) and their aqueous extract did not significantly affect serum enzymes, albumin and bilirubin levels. 
However, treatment with powder (2 g/kg), methanolic extract (0.6 g/kg), Akseer-e-Jigar (1 g/kg) and silymarin (50 
mg/kg) in both pre and post-treatment studies significantly prevented the paracetamol-induced rise of serum enzymes 
and bilirubin levels whereas serum albumin was raised after treatment with these drugs. It is conceivable, therefore, 
that Rheum emodi roots and Akseer-e-Jigar possess hepatoprotective principles that can prevent and/or treat liver 
damage due to paracetamol. The study has supported empirical use of the plant and its compound preparation used in 
traditional medicine.
 
Introduction
      
Liver diseases have become one of the major causes of morbidity and mortality in man and animals all over globe 
and hepatotoxicity due to drugs appears to be the most common contributing factor [Nadeem, 1997]. The use of 
natural remedies for the treatment of liver diseases has a long history and medicinal plants and their derivatives are 
still used all over the world in one form or the other for this purpose. Scientific evaluation of plants has often shown 
that active principles in these are responsible for therapeutic success. A large number of medicinal plants have been 
tested and found to contain active principles with curative properties against a variety of diseases [Lewis, 1977]. 
Recent experience has shown that plant drugs are relatively non-toxic, safe and even free from serious side effects 
[Momin, 1987].
Rheum emodi root has been claimed to possess purgative, anthelmintic and hepatoprotective actions [Saeed,1970] 
and its tuber as bitter, laxative, appetite stimulant, diuretic, anti-bilious, and curative for sore eyes and bruises [Alam, 
2005 ]. It has also been reported to have antifungal [Agarwal, 200] and hypoglycaemic properties [Li J, 1997]. 
Although Rheum emodi root is being commonly used in traditional medicine as hepatoprotective yet its efficacy has 
not been well documented. Therefore, a study was conducted to investigate hepatoprotective effect of crude drug as 
well as aqueous and methanolic extracts of Rheum emodi roots and a popular compound preparation containing the 
roots against paracetamol-induced liver damage in albino rats.
 
Materials and Methods
 
Plant Material
 
Dried Rheum emodi roots locally called “Revand chini” were purchased from local herbal market. R. emodi roots 
were identified and authenticated by Department of Botany, University of Agriculture, Faisalabad. The dried roots 
were powdered finely with herbal grinder and stored in well-closed cellophane bags at 4 °C temperature.
 
Chemicals and Drugs
            
            Paracetamol and methanol were obtained from GSK Pakistan Ltd., Karachi and Merck, Germany, 
respectively. Silymarin was that of Abbott Laboratories, Karachi. The diagnostic kits for the estimation of ALT, 
AST, ALP, albumin and bilirubin were that of Breuer & Breuer, Germany; Merck, Germany; Medi, Italy; Giesse, 
Italy; Human, Germany, respectively. Akseer-e-Jigar was supplied by Al-Mansoor Clinics, Medina Town, Faisalabad 
which consists of R. emodi roots, ammonium chloride and potassium nitrate.
 
Experimental Animals
 
Healthy adult male albino Wister rats weighing 200-300 g were procured from National Institute of Health, 
Islamabad. Three animals per cage were housed in metal cages and free access to standard feed and tap water was 
provided ad libitum. The animals were kept under observation for one week before experimentation under usual 
managemental conditions in the animal room. The animals were kept under stander laboratory conditions and the 
study protocol was approved by local ethical committee.
 
Induction of hepatic toxicity
 
Hepatic toxicity in rats was induced by oral administration of a single dose of paracetamol (640 mg/kg) using 1% 
methylcellulose (13 ml/kg) solution as vehicle. The test drugs were administered to the treatment groups orally, using 
normal saline (10 ml/kg) as vehicle. The control animals received equal volumes of the vehicle.
 
 
Pretreatment Hepatoprotective Effects 
 
            Animals were randomly divided into 9 groups of six animals each. Group І, serving as control, received 4 
doses of normal saline (10 ml/kg) at 12 hrs intervals; 1 hr after the last saline dose, 1% methylcellulose solution (13 
ml/kg) was administered. Group ІІ received 4 doses of normal saline (10 ml/kg) at 12 hrs intervals; 1 hr after the last 
saline dose, paracetamol (640 mg/kg) was administered. Group ІІІ received 4 doses of powdered Rheum emodi roots 
(1 g/kg) at 12 hrs intervals; 1 hr after the last dose, paracetamol (640 mg/kg) was administered. Group ІѴ received 4 
doses of powdered Rheum emodi roots (1.5 g/kg) at 12 hrs intervals; 1 hr after the last dose, paracetamol (640 mg/kg) 
was administered. Group Ѵ received 4 doses of powdered Rheum emodi roots (2 g/kg) at 12 hrs intervals; 1 hr after 
the last dose, paracetamol (640 mg/kg) was administered. Groups ѴІ, VII, VIII & IX were treated similar to the 
group V except that they received methanolic extract of Rheum emodi root (0.6 g/kg), aqueous extract of Rheum 
emodi roots (eq. to 2 g/kg), Akseer-e-Jigar (1 g/kg) and Silymarin (50 mg/kg), respectively.   
 
Post-treatment Hepatoprotective Effects of Test Drugs
 
      Animals were randomly divided into 9 groups of six animals each. Group І, serving as control, was administered 
the vehicle (1% methylcellulose orally; 13 ml/kg) at 0 hr and 4 doses of normal saline (10 ml/kg) at 6 hours intervals. 
Group ІІ received paracetamol (640 mg/kg) at 0 hr and 4 doses of normal saline (10 ml/kg) at 6 hrs intervals, Group 
ІІІ received paracetamol (640 mg/kg) at 0 hr  and 4 doses of powdered Rheum emodi roots (1 g/kg) at 6 hrs intervals, 
Group ІѴ was given paracetamol (640 mg/kg) at 0 hr  and 4 doses of powdered Rheum emodi roots (1.5 mg/kg) at 6 
hrs intervals, Group Ѵ received paracetamol (640 mg/kg) at 0 hr and 4 doses of powdered Rheum emodi roots (2  g/
kg) at 6 hrs intervals, Groups ѴІ, VII, VIII & IX were treated similar to the group V except that they received 
methanolic extract of Rheum emodi roots (0.6 g/kg), aqueous extract of Rheum emodi roots (eq. to 2 g/kg), Akseer-e-
Jigar (1 g/kg) and Silymarin (50 mg/kg), respectively.        
 
Preparation of Methanolic and Aqueous Extracts of Roots: 
Methanolic Extract
Methanolic extract was prepared by continuous extraction technique using Soxhlet’s apparatus. Slow heating at 40 °
C and continuous stirring evaporated the methanolic extract. The process of evaporation was continued till complete 
evaporation of methanol was ensured. The dried extract was dissolved in 1% methylcellulose sol. just before 
administration to rats. The methanolic extract eq. to 2 g/kg b.w. of powdered R. emodi roots i.e. 0.6 g/kg was 
administered orally.
 
Aqueous Extract
 
A weighed amount of powdered roots was macerated in distilled water at room temperature and agitated occasionally 
for one day [Osol,1975]. Filtered through a fine filter paper and marc was pressed to avoid loss. The extract obtained 
was in liquid form at room temperature. The extract was stored in a sterilized PVC bottle at 4 °C. The extract was 
used in liquid form by calculating the volume eq. to the extract from 2 g of powdered Rheum emodi roots. 
 
Collection of Blood Samples
Blood samples were collected 24 hrs after the last treatment. Animals were anaesthetized with ether, and put in a 
desiccator. Up to 5-8 ml of blood from each rat was collected by cutting the carotid artery in centrifuge tubes. These 
blood samples were kept at 4°C for a period of 12 hrs. Serum was separated by centrifugation (3000 r.p.m., for 15 
min.) The serum thus obtained was used for determination of levels of ALT, AST, ALP, albumin and bilirubin.
 
Determination of Serum Enzymes, Albumin and Bilirubin
Serum samples were analyzed by following kinetic methods using B.T.S. 330 (Biosystems, Spain). Diagnostic kits 
have been used in the above mentioned semi-automated analyzer for the quantitative estimation of ALT (SGPT), 
AST (SGOT) ALP, albumin and bilirubin.
 
Statistical Analysis
The data obtained were analyzed by using one way analysis of variance technique. The means were compared for 
significance by using Least Significance Difference (LSD) test (Steel and Torrie, 1980).  
 
Results
 
Pretreatment Hepatoprotective Effects 
            
            Paracetamol-treated group had ALT level which was significantly higher than control (Table 1). The 
powdered R. emodi roots (2g/kg), methanolic extract, Akseer-e-Jigar and silymarin pretreatment inhibited the rise of 
serum ALT, AST, ALP and bilirubin levels effectively as their values were non-significantly different from control 
whereas level of albumin was decreased. The lower doses of R. emodi roots and their aqueous extract did not 
significantly affect the paracetamol-induced rise of serum enzymes and bilirubin whereas the decline in albumin level 
was also not prevented (Table 1).
 
Table 1. Pretreatment hepatoprotective effects of powdered Rheum emodi roots, methanolic extract, aqueous extract, 
Akseer-e-Jigar and Silymarin on paracetamol-induced rise of ALT, AST, ALP, albumin and bilirubin (total and 
direct).
 
  Group Treatments ALT
(U/L)
AST
(U/L)
ALP
(U/L)
Albumin
(g/dl)
Bilirubin
Tot. (g/dl)
Bilirubin
Dir. (g/dl)
1 Saline + Vehicle 36.33 ± 
2.03 D 
49.83 ± 
2.73 F
129.2 ± 
11.7 G
3.50 ± 0.10 A 0.43 ± 0.07 E 0.25 ± 0.04 E
2 Saline+ Paracetamol 693.7 ± 
30.0 A
921.7 ± 
23.6 A
369.5 ± 
15.8 A
2.33 ± 0.13 E 4.70 ± 0.11 A 3.26 ± 0.10 A
3 R. emodi roots (1 g/
kg) + Paracetamol
527.8 ± 
25.2 B
608.5 ± 
44.3 B
312.2 ± 
15.6 B
2.78 ± 0.06 D 3.60 ± 0.24 B 2.41 ± 0.18 B
4 R. emodi roots (1.5g/
kg) + Paracetamol
194.7 ± 
23.9 C
277.0 ± 
31.0 CD
223.5 ± 
15.3 CD
2.85 ± 0.08 CD 1.71 ± 0.16 C 1.15 ± 0.09 C
5 R. emodi roots (2 g/
kg) + Paracetamol
52.67 ± 
2.91 D
111.0 ± 
15.1 FG
138.5 ± 
15.2 FG
3.28 ± 0.14 AB 1.11 ± 0.11 D 0.61 ± 0.08 D
6 Methanolic Extract + 
Paracetamol
42.17 ± 
2.10 D
62.50 
±4.15 EFG
165.8 ± 
12.7 EFG
3.25 ± 0.08 AB 0.41 ± 0.05 E 0.28 ± 0.04 E
7 Aqueous Extract + 
Paracetamol
66.17 ± 
4.61 D
172.7 ± 
12.2 C
227.8 ± 
18.7 C
3.15 ± 0.14 B 1.03 ± 0.07 D 0.60 ± 0.03 D
8 Akseer-e-Jigar + 
Paracetamol
54.67 ± 
5.14 D
76.67 ± 
8.57 DE
186.0 ± 
5.21 DE
3.06 ± 0.05 
BCD
0.51 ± 0.10 E 0.35 ± 0.07 DE
9 Silymarin + 
Paracetamol
48.50 ± 
3.75 D
81.00 ± 
6.94 EF
169.8 ± 
9.65 EF
3.13 ± 0.06 BC 0.51 ± 0.08 E 0.31 ± 0.07 E
 
Means sharing similar letters are statistically non-significant (P > 0.05), n=6
 
 
Post-treatment Hepatoprotective Effects 
 
            Table 2 shows that treatment with test substances significantly lowered paracetamol-induced rise of ALT 
level except the lower doses of R. emodi roots. The effect was highest with methanolic extract followed by Akseer-e-
Jigar and silymarin, respectively. The test drugs also lowered serum AST, ALP and bilirubin levels in paracetamol 
treated rats (Table 2). The maximum decrease in the levels of AST and bilirubin were resulted from methanolic 
extract while maximum depression in ALP level was caused by Akseer-e-Jigar. The methanolic extract proved to be 
most efficient in increasing the decreased level of albumin in paracetamol treated rats (Table 2).  
 
Table 2. Post-treatment hepatoprotective effects of powdered Rheum emodi roots, methanolic extract, aqueous 
extract, Akseer-e-Jigar and Silymarin on paracetamol-induced rise of ALT, AST, ALP, albumin, bilirubin (total and 
direct).
 
Group
 
Treatment ALT
(U/L)
AST
(U/L)
ALP
(U/L)
Albumin
(g/dl)
Bilirubin
Tot. (g/dl)
Bilirubin
Dir. (g/dl)
1 Saline + Vehicle 43.67 ± 
2.76 E
57.67 ± 
2.54 F
141.0 ± 
9.04 EF
3.43 ± 0.11 A 0.31 ± 0.07 G 0.21 ± 0.04 F
2 Saline+ 
Paracetamol
690.5 ± 
30.2 A
1027.5 ± 
30.2 A
385.5 ± 
10.0 A
2.08 ± 0.08 F 5.11 ± 0.12 A 3.43 ± 0.11 A
3 R. emodi roots (1 g/
kg) + Paracetamol
567.0 ± 
31.3 B
812.8 ± 
29.6 B
312.5 ± 
14.0 B 
2.56 ± 0.12 E 4.36 ± 0.21 B 2.90 ± 0.22 B
4 R. emodi roots 
(1.5g/kg) + 
Paracetamol
220.5 ± 
16.6 C
354.8 ± 
26.4 C
236.0 ± 
10.5 C
2.85 ± 0.08 D 2.81 ± 0.18 C 1.93 ± 0.12 C
5 R. emodi roots (2 g/
kg) + Paracetamol
66.83 ± 
5.18 DE
136.0 ± 
17.6 DE
173.2 ± 
17.9 DE
3.10 ± 0.07 BC 0.98 ± 0.10 DE 0.60 ± 0.09 DE
6 Methanolic Extract 
+ Paracetamol
51.67 ± 
2.44 DE
74.50 ± 
3.92 F
153.3 
±13.6 EF
3.26 ± 0.09 AB 0.58 ± 0.07 FG 0.33 ± 0.06 EF
7 Aqueous Extract + 
Paracetamol
89.00 ± 
4.44 D
183.3 ± 
14.1 D
204.2 ± 
18.5 CD
2.98 ± 0.07 CD 1.20 ± 0.03 D 0.66 ± 0.03 D
8 Akseer-e-Jigar + 
Paracetamol
57.50 ± 
4.99 DE
93.83 ± 
5.76 EF
130.0 ± 
6.89 F
3.10 ± 0.03 BC 0.78 ± 0.10 EF 0.51 ± 0.07 
DEF
9 Silymarin + 
Paracetamol
58.83 ± 
2.87 DE
101.0 ± 
5.79 EF
140.83 ± 
8.21 EF
3.08 ± 0.04 
BCD
0.63 ± 0.06 FG 0.35 ± 0.05 EF
 
Means sharing similar letters are statistically non-significant (P > 0.05), n=6
 
Discussion
 
            Paracetamol-induced hepatic damage has been commonly used as experimental model for screening of newer 
hepatoprotectives [Plas,1982] and the extent of hepatic damage is assessed by the circulating levels of released 
cytoplasmic enzymes such as ALT, AST and ALP [Singh,1998]. The data obtained in the present study have shown 
that pretreatment of animals with test drugs have resulted in prevention of rise of serum enzymes, bilirubin and 
decline of albumin levels (Table 1). It is, conceivable, therefore that powdered R. emodi root, its methanolic extract 
and Akseer-e-Jigar contain MDME inhibitory constituents that provide hepatoprotection [Agarwal, 2000; Li J, 1975]. 
All the test drugs have marked effect, excepting the low doses of R. emodi and its aqueous extract that have failed to 
yield significant change in the curative trials. These results show that the powdered Rheum emodi in high dose, its 
methanolic extract and Akseer-e-Jigar have hepatoprotective principles. Our data have also supported empirical use 
of the plant drug in traditional eastern medicine and the herbal preparation, Akseer-e-Jigar being used very 
commonly by Hakims in the treatment of some liver disorders, 
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